DUBLIN, June 28, 2022 /PRNewswire/ -- The "Clinical Trials Market Size, Share & Trends Analysis Report by Phase (Phase I, Phase II, Phase III, Phase IV), by Study Design, by Indication (Pain Management, Oncology, CNS Condition, Diabetes, Obesity), by Region, and Segment Forecasts, 2022-2030" report has been added to ResearchAndMarkets.com's offering.
The global clinical trials market size is expected to reach USD 78.3 billion by 2030, registering a CAGR of 5.8%
An increase in the volume and complexity of clinical trials has been witnessed lately, which plays an important role in the R&D of new drugs and products. The market witnessed a decline of 6% in 2020 owing to the COVID-19 pandemic. However, the market is projected to recover from 2021 onwards. In addition, clinical trials have become increasingly costly, adding to the overall cost of developing a drug.
The high number of people affected by the disease further depicts an increasing need for therapeutics & vaccines. Currently, there are 288 therapeutics and 106 vaccines under development, out of which, nearly 7.0% of therapeutics are in Phase IV, 21.0% in Phase III, and 43.0% & 13.0% in Phase II & Phase I, respectively.
The pandemic has resulted in the global disruption of traditional onsite clinical trials. Hence, regulatory bodies worldwide have undertaken various initiatives for fast-tracking clinical trials for the development of innovative solutions.
One such instance is Solidarity, an international clinical trial launched by the WHO to find effective treatment against COVID-19. Although the pandemic has forced many medical device & drug developers to revise the approach to such crises, integrating best practices within clinical trial procedures & adapting to virtual trials, which can support the continuous development of therapeutics.
Clinical Trials Market Report Highlights
The phase III clinical trials segment dominated the market with a 53.4% share in 2021. This can be attributed to the complexity of this phase.
The interventional design segment accounted for the largest share of 45.7% in 2021 in the study design segment owing to the increasing demand for the intervention for clinical trials by researchers.
North America held 50.7% of the market share in 2021. Favorable government initiatives and the presence of a large number of players in the U.S. that offer advanced services are responsible for market growth.
The Asia Pacific region is expected to grow at the fastest CAGR of 6.8% over the forecast period owing to the increasing patient pool and cost-efficient services.
Clinical Trials Market-Competitive Analysis
Chapter 3. Clinical Trials Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook 3.2. Penetration & Growth Prospect Mapping
3.3. Product Pipeline Analysis, by Stage
3.3.1. Therapeutics in Development
3.3.2. Vaccines in Development
3.4. Fast-Track of Clinical Trials
3.4.1. FDA Initiative-CTPA
3.4.2. U.K. Initiative-ACCORD
3.4.3. ASIA Pacific Initiative-DCGI
3.5. Solidarity Clinical Trials
3.5.1. Participation in Solidarity Trials
3.5.2. Solidarity Clinical Trial for Vaccines
3.7.1. Companies with Phase 1 Trial Disruption
3.7.2. Companies with Phase 2 Trial Disruption 3.7.3. Companies with Phase 3 Trial Disruption
3.8.1.1. Increasing Research and Development Promoting Outsourcing
3.8.1.2. Adoption of New Technology in Clinical Research
3.8.1.4. Globalization of Clinical Trials
3.8.2.1. Stringent Regulatory Policies for Patient Enrollment
3.8.2.2. Lack of Skilled Workforce in Clinical Research
3.8.3. Industry Challenges
3.8.3.1. Rising Cost of Clinical Trial
3.9. Clinical Trials: Market Analysis Tools
3.9.1. Industry Analysis-Porter's
3.9.1.3. Substitution Threat
3.9.1.4. Threat from New Entrant
3.9.2.1. Political Landscape
3.9.2.4. Technology Landscape
3.9.3. Major Deals & Strategic Alliances Analysis
Chapter 4. Clinical Trials Market: Segment Analysis, by Phase, 2017-2030 (USD Million)
4.2. Phase Market Share Analysis, 2021 & 2030
4.4. Global Clinical Trials Market, by Phase, 2017 to 2030 4.5. Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the Following
Chapter 5. Clinical Trials Market: Segment Analysis, by Study Design, 2017-2030 (USD Million)
5.2. Study Design Market Share Analysis, 2021 & 2030 5.4. Global Clinical Trials Market, by Study Design, 2017 to 2030
5.5. Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the following
Chapter 6. Clinical Trials Market: Segment Analysis, by Indication, 2017-2030 (USD Million)
6.2. Indication Market Share Analysis, 2021 & 2030
6.4. Global Clinical Trials Market, by Indication, 2017 to 2030
6.5. Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the following
Chapter 7. Clinical Trials Market: Segment Analysis, Indication by Study Design, 2017-2030 (USD Million)
7.1. Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the following
Chapter 8. Clinical Trials Market: Segment Analysis, by Sponsor, 2017-2030 (USD Million)
8.1. Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the Following
8.1.1. Pharmaceutical & Biopharmaceutical Companies
8.1.2. Medical Device Companies
Chapter 9. Clinical Trials Market: Regional Market Analysis, by Region, 2017-2030 (USD Million)
9.2. Regional Market Share Analysis, 2021 & 2030
9.3. Regional Market Dashboard
9.4. Regional Market Share, 2020
9.5. Market Size, & Forecasts, and Trend Analysis, 2017 to 2030
Chapter 10. Clinical Trials Market-Competitive Analysis
For more information about this report visit https://www.researchandmarkets.com/r/k64zf1
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Fax (outside U.S.): +353-1-481-1716
Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg